Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Obesity 2 Polycystic Ovary Syndrome 1 Overweight 1 Breast Neoplasms 1

Interventions

Metformin 41 Clomiphene 17 Letrozole 6 Menotropins 5 Folic Acid 5 drospirenone and ethinyl estradiol combination 4 Liraglutide 4 Chorionic Gonadotropin 4 cetrorelix 3 Triptorelin Pamoate 3 Progesterone 3 Pioglitazone 3 Leuprolide 3 Inositol 3 Exenatide 3 Ethinyl Estradiol 3 Estradiol 3 Vitamins 2 Sperm Injections, Intracytoplasmic 2 Sitagliptin Phosphate 2 Simvastatin 2 Gonadotropins 2 Glycoprotein Hormones, alpha Subunit 2 Exercise 2 Escitalopram 2 Cyproterone acetate, ethinyl estradiol drug combination 2 Contraceptives, Oral 2 Cholecalciferol 2 Carnitine 2 Canagliflozin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Polycystic Ovary Syndrome × Tirzepatide × Clear all

NCT07326111 2026-01-08

PERIODS

University of Bonn

Phase 4 Recruiting

Obesity, Polycystic Ovary Syndrome, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡